|
Post by biffn on Jun 3, 2021 14:04:47 GMT -5
I was thinking that, adding to the competitive news item,the meme traders may have been unloading any MNKD they were holding to load up on AMC and GME earlier this week.
|
|
|
Post by biffn on Jun 3, 2021 14:08:08 GMT -5
Also, it should benefit us to clear out a lot of day traders and there were certainly enough buyers seeing it as a bargain opportunity this week.
|
|
|
Post by peppy on Jun 3, 2021 16:27:03 GMT -5
MNKD Nasdaq real time volume, 1,656,724 shares. MNKD Nasdaq summary volume, 2,679,236 shares. Avg. Volume 4,401,779 $3.80. +0.09 (+2.43%) At close: 4:00PM EDT
|
|
|
Post by cretin11 on Jun 4, 2021 8:32:17 GMT -5
Also, it should benefit us to clear out a lot of day traders and there were certainly enough buyers seeing it as a bargain opportunity this week. Yep, this move down below $4 is a good thing, don’t let anyone say otherwise.
|
|
|
Post by joeypotsandpans on Jun 4, 2021 11:55:57 GMT -5
Peppy, where is the next level of support? Where do your charts tell you we are headed to? $3.30 is the 200 day. $3.14 and $3.12 this last delusion low. This ☝️☝️☝️ (test of 200d) feels inevitable, whether it's 3.30,3.35,3.40 in the next week or so...should pass the test with inhalable colors IMO.😉
|
|
|
Post by boca1girl on Jun 4, 2021 12:42:03 GMT -5
I’ve got a protective by order in at 3.25 so that it will not go that low. 😎
|
|
|
Post by joeypotsandpans on Jun 4, 2021 12:56:52 GMT -5
I’ve got a protective by order in at 3.25 so that it will not go that low. 😎 Thanks for the tipoff Boca, I just put mine in @ 3.26, I'm pulling a price is right strategy on you lol 🤪🤣😎😎
|
|
|
Post by winner on Jun 4, 2021 13:13:27 GMT -5
Excerpt from a Clement post back in April
--------------------------- "Priority Review
A drug receives a Priority Review if CDER determines that the drug could potentially provide a significant advance in medical care. The drug is reviewed in an expedited time line: within eight months instead of the standard 12 months."
---------------------------
Apparently we will know within the next 18 days if the FDA will be giving UTHR A Priority Review. I.M.H.O. if the FDA rejects this request, I will wish I had sold at the current price. Time will tell. Best of luck to all MNKD Equity share holders....
|
|
|
Post by peppy on Jun 4, 2021 15:29:04 GMT -5
MNKD Nasdaq real time volume, 2,190,265 shares. MNKD Nasdaq summary volume, 3,645,383 shares. Avg. Volume 4,280,712
$3.61. -0.19 (-5.00%) At close: 4:00PM EDT
|
|
|
Post by mytakeonit on Jun 4, 2021 15:33:49 GMT -5
And ... one year ago on 06/04/20 we were at $1.42 ... interesting ... don't you think?
But, that's mytakeonit
|
|
|
Post by awesomo on Jun 4, 2021 15:38:52 GMT -5
And ... one year ago on 06/04/20 we were at $1.42 ... interesting ... don't you think? But, that's mytakeonit About as interesting as being at 4.54 last Friday, or 6.14 four months ago.
|
|
|
Post by sportsrancho on Jun 4, 2021 15:41:18 GMT -5
Excerpt from a Clement post back in April --------------------------- "Priority Review A drug receives a Priority Review if CDER determines that the drug could potentially provide a significant advance in medical care. The drug is reviewed in an expedited time line: within eight months instead of the standard 12 months." --------------------------- Apparently we will know within the next 18 days if the FDA will be giving UTHR A Priority Review. I.M.H.O. if the FDA rejects this request, I will wish I had sold at the current price. Time will tell. Best of luck to all MNKD Equity share holders.... I just bought more shares in my Roth because I anticipate getting it ...of course there’s people betting against that, that’s why the stock is going down in my opinion..... it could jump big time on the news!
|
|
|
Post by golfeveryday on Jun 4, 2021 15:53:42 GMT -5
Excerpt from a Clement post back in April --------------------------- "Priority Review A drug receives a Priority Review if CDER determines that the drug could potentially provide a significant advance in medical care. The drug is reviewed in an expedited time line: within eight months instead of the standard 12 months." --------------------------- Apparently we will know within the next 18 days if the FDA will be giving UTHR A Priority Review. I.M.H.O. if the FDA rejects this request, I will wish I had sold at the current price. Time will tell. Best of luck to all MNKD Equity share holders.... I just bought more shares in my Roth because I anticipate getting it ...of course there’s people betting against that, that’s why the stock is going down in my opinion..... it could jump big time on the news! they paid $105M for priority review. They are getting it.
|
|
|
Post by mnkdfann on Jun 4, 2021 15:59:18 GMT -5
I just bought more shares in my Roth because I anticipate getting it ...of course there’s people betting against that, that’s why the stock is going down in my opinion..... it could jump big time on the news! they paid $105M for priority review. They are getting it. That's what I thought.
|
|
|
Post by mytakeonit on Jun 4, 2021 16:10:27 GMT -5
And on 6/30/20 we were at $1.75 ... and on 6/30/21 we will be at $10 ... interesting ... don't you think? But, that's mytakeonit I wish I could have a ROTH ... I'd load it up to the max right now. Which actually isn't very much.
|
|